Novartis heart failure drug cuts death by 37 percent: study

LOS ANGELES (Reuters) - An experimental Novartis AG drug to treat hospitalized acute heart failure patients reduced deaths by 37 percent compared with a placebo and appeared to be safe, according to data from a late stage clinical trial presented on Tuesday.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/_GQJe1EOtVA/us-heart-novartis-heartfailure-idUSBRE8A602C20121107

john keells stock rpm mortgage alamo airline industry fuel prices